Comparative Study of Donepezil-Loaded Formulations for the Treatment of Alzheimer’s Disease by Nasal Administration
Open Access
Abstract
Alzheimer’s disease is characterized by a progressive deterioration of neurons resulting in a steady loss of cognitive functions and memory. Many treatments encounter the challenge of overcoming the blood–brain barrier, thus the intranasal route is a non-invasive effective alternative that enhances the drug delivery in the target organ–the brain–and reduces the side effects associated with systemic administration. This study aimed at developing intranasal gels of donepezil as an approach to Alzheimer’s disease. Three different gels were elaborated and characterized in terms of pH, morphology, gelation temperature, rheology, and swelling. An in vitro release study and an ex vivo permeation in porcine nasal mucosa were conducted on Franz diffusion cells. The tolerability of the formulations was determined by the cytotoxicity in human nasal cells RPMI 2650. Results showed that pluronic gels exhibit the higher release rate and enhanced permeation compared to chitosan gel. Moreover, the combination of Pluronic F-127 and Transcutol® P exerted a synergic effect on the permeation of donepezil through the nasal mucosa. The resulting gels showed suitable tolerance in the RPMI 2650 cell line and physicochemical characteristics for intranasal delivery, and thus gel formulations administered by nasal mucosa could be an alternative strategy to improve the bioavailability of donepezil.Keywords
This publication has 32 references indexed in Scilit:
- The nasal delivery of nanoencapsulated statins – an approach for brain deliveryInternational Journal of Nanomedicine, 2016
- Formulation and device design to increase nose to brain drug deliveryJournal of Drug Delivery Science and Technology, 2016
- A review of the nonclinical safety of Transcutol®, a highly purified form of diethylene glycol monoethyl ether (DEGEE) used as a pharmaceutical excipientFood and Chemical Toxicology, 2014
- Chitosan in nasal delivery systems for therapeutic drugsJournal of Controlled Release, 2014
- Semisolid formulations containing cetirizine: human skin permeation and topical antihistaminic evaluation in a rabbit modelArchives of Dermatological Research, 2014
- Fabrication and Characteristics of Chitosan Sponge as a Tissue Engineering ScaffoldBioMed Research International, 2014
- Animal models of Alzheimer disease: historical pitfalls and a path forwardALTEX, 2014
- RPMI 2650 epithelial model and three-dimensional reconstructed human nasal mucosa as in vitro models for nasal permeation studiesEuropean Journal of Pharmaceutics and Biopharmaceutics, 2010
- Donepezil: potential neuroprotective and disease-modifying effectsExpert Opinion on Drug Metabolism & Toxicology, 2008
- Temperature-dependent rheological behavior of Pluronic F-127 aqueous solutionsInternational Journal of Pharmaceutics, 1987